ANGLE plc: Angle PLC Announces Identifying Therapeutic Targets in TNBC Patients

PARSORTIX SHOWS POTENTIAL FOR IDENTIFYING THERAPEUTIC TARGETS IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCERParsortix system harvests intact CTCs for whole genome sequencing identifying multiple actionable

Related Keywords

Mexico ,Australia ,Japan ,Milan ,Lombardia ,Italy ,United States ,India ,Guildford ,Western Australia ,United Kingdom ,China ,Canada ,London ,City Of ,American ,Ciara Martin ,Toby Flaux ,Thomas Bective ,Milo Bonser ,Andrew Newland ,Jen Clarke ,Vera Cappaletti ,Ian Griffiths ,Simon Conway ,Max Jones ,London Stock Exchange ,National Cancer Institute Of Milan ,Laboratory Developed Tests Ldts ,Philips ,Department Of Experimental Oncology ,American Cancer Society ,Biomarkers Unit ,Experimental Oncology ,National Cancer Institute ,Chief Executive ,Journal Scientific Reports ,Joint Broker ,Frequently Used Terms ,Key Opinion Leaders ,Laboratory Developed Tests ,London Stock ,Angle ,Nnounces ,Identifying ,Herapeutic ,Targets ,Nbc ,Patients ,